Mindpeak
Private Company
Total funding raised: $17.5M
Overview
Mindpeak is a Hamburg-based AI/ML company operating at the intersection of digital pathology and precision medicine. It has developed a suite of CE-marked, deep learning-based software products that automate the analysis of immunohistochemistry (IHC) and H&E-stained tissue samples, primarily for oncology biomarkers like PD-L1, HER2, and Ki-67. The company's value proposition centers on '0-click' integration, offering both standalone and deeply embedded solutions within partner laboratory information systems to improve pathologist efficiency and diagnostic consistency. Mindpeak appears to be in a commercial, revenue-generating stage, serving diagnostic labs, hospitals, and research institutions.
Technology Platform
Proprietary deep learning platform for automated, '0-click' analysis of digital histopathology images (H&E, IHC). Specializes in tumor identification, cell detection/classification, and biomarker quantification with deep integration into laboratory software workflows.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Mindpeak operates in a highly competitive space with rivals including Paige, PathAI, Ibex Medical Analytics, and Proscia. Large players like Roche (with its navify digital pathology platform) and Philips also offer or integrate AI solutions. Mindpeak's differentiation centers on its '0-click,' deeply integrated approach and a focused portfolio of CE-marked, clinically validated applications.